Saturday, January 31, 2026

Worried About Radiation, South Korea Tests Waters Near North Korean Border

South Korea launches an investigation into potential radioactive contamination from North Korea's uranium refinery via the Ryesong River.

North Korea’s Princess? Ju Ae’s Special Treatment at Military Ceremony Unveiled

North Korean leader Kim Jong Un recently attended an official event with his daughter Ju Ae for the first time in over 80 days.

North Korea Expands Oil Storage: New Tanks Spotted in Nampo Port

VOA reported that a new oil storage tank had been installed in the densely packed oil facility area of Nampo Port in North Korea.

Tag: biopharmaceuticals

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.